The PiZ transgenic mouse model is widely utilised in preclinical studies of AAT aggregation as these mice overexpress human Z‐AAT protein and recapitulate numerous aspects of liver disease associated with human AATD. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.